Susquehanna International Group’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.42M Sell
161,493
-3,922
-2% -$34.6K ﹤0.01% 2754
2025
Q1
$1.24M Buy
165,415
+60,785
+58% +$455K ﹤0.01% 3001
2024
Q4
$873K Sell
104,630
-110,168
-51% -$919K ﹤0.01% 3203
2024
Q3
$1.49M Buy
214,798
+76,294
+55% +$529K ﹤0.01% 2202
2024
Q2
$679K Buy
138,504
+49,895
+56% +$244K ﹤0.01% 3077
2024
Q1
$514K Sell
88,609
-26,253
-23% -$152K ﹤0.01% 3504
2023
Q4
$752K Buy
114,862
+70,457
+159% +$461K ﹤0.01% 3262
2023
Q3
$214K Buy
44,405
+2,619
+6% +$12.6K ﹤0.01% 4469
2023
Q2
$213K Sell
41,786
-159,386
-79% -$813K ﹤0.01% 4594
2023
Q1
$1.11M Buy
201,172
+31,158
+18% +$171K ﹤0.01% 2743
2022
Q4
$780K Buy
170,014
+25,269
+17% +$116K ﹤0.01% 2608
2022
Q3
$903K Sell
144,745
-19,156
-12% -$120K ﹤0.01% 2678
2022
Q2
$731K Sell
163,901
-25,061
-13% -$112K ﹤0.01% 2839
2022
Q1
$950K Buy
188,962
+114,913
+155% +$578K ﹤0.01% 2882
2021
Q4
$645K Sell
74,049
-427,882
-85% -$3.73M ﹤0.01% 3443
2021
Q3
$4.68M Buy
501,931
+142,870
+40% +$1.33M ﹤0.01% 1211
2021
Q2
$4.6M Buy
359,061
+162,002
+82% +$2.08M ﹤0.01% 1318
2021
Q1
$1.81M Buy
+197,059
New +$1.81M ﹤0.01% 2238
2020
Q2
Sell
-3,608
Closed -$13K 5044
2020
Q1
$13K Sell
3,608
-423
-10% -$1.52K ﹤0.01% 4396
2019
Q4
$24K Sell
4,031
-2,510
-38% -$14.9K ﹤0.01% 3846
2019
Q3
$72K Buy
6,541
+4,148
+173% +$45.7K ﹤0.01% 4148
2019
Q2
$67K Sell
2,393
-5,715
-70% -$160K ﹤0.01% 4231
2019
Q1
$217K Buy
8,108
+4,783
+144% +$128K ﹤0.01% 2488
2018
Q4
$95K Buy
3,325
+616
+23% +$17.6K ﹤0.01% 3206
2018
Q3
$208K Buy
2,709
+1,875
+225% +$144K ﹤0.01% 2727
2018
Q2
$87K Buy
+834
New +$87K ﹤0.01% 3315
2018
Q1
Sell
-1,068
Closed -$69K 4656
2017
Q4
$69K Buy
+1,068
New +$69K ﹤0.01% 3389
2016
Q2
Sell
-3,082
Closed -$715K 4185
2016
Q1
$715K Buy
3,082
+1,500
+95% +$348K ﹤0.01% 2333
2015
Q4
$503K Buy
+1,582
New +$503K ﹤0.01% 2981